Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine vs Standard Chemotherapy in Older Women with Early Breast Cancer
NCT00024102Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Sep 2001
- Primary completion
- May 2008
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of capecitabine in breast cancer, sponsored by Cancer and Leukemia Group B. Started Sep 2001; status: completed.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00024102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00024102.